MM

Matthew Arnold Marx

MT Mirati Therapeutics: 26 patents #1 of 63Top 2%
AB Array Biopharma: 9 patents #76 of 335Top 25%
Pfizer: 4 patents #1,262 of 5,153Top 25%
AP Agouron Pharmaceuticals: 1 patents #185 of 327Top 60%
📍 San Diego, CA: #1,174 of 23,606 inventorsTop 5%
🗺 California: #15,733 of 386,348 inventorsTop 5%
Overall (All Time): #110,141 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
12421228 Naphthyridine derivatives as PRC2 inhibitors John Michael Ketcham, Aaron Craig Burns 2025-09-23
12421253 Tetrahydropyridopyrimidine pan-KRas inhibitors Xiaolun Wang, Anthony Ivetac, Svitlana Kulyk, John David Lawson, Christopher Ronald Smith 2025-09-23
12398154 Azaquinazoline pan-KRas inhibitors Xiaolun Wang, Svitlana Kulyk, John David Lawson, Christopher Ronald Smith 2025-08-26
12371435 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2025-07-29
12304915 SOS1 inhibitors John Michael Ketcham, Christopher Ronald Smith, John David Lawson, Aaron Craig Burns, Xiaolun Wang +2 more 2025-05-20
12252493 Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer John Michael Ketcham, Aaron Craig Burns 2025-03-18
11999753 Tetrahydropyridopyrimidine pan-KRas inhibitors Xiaolun Wang, Anthony Ivetac, Svitlana Kulyk, John David Lawson, Christopher Ronald Smith 2024-06-04
11964989 KRas G12D inhibitors Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more 2024-04-23
11932633 KRas G12C inhibitors Matthew Lee, James F. Blake, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +5 more 2024-03-19
11702418 SOS1 inhibitors John Michael Ketcham, Christopher Ronald Smith, John David Lawson, Aaron Craig Burns, Xiaolun Wang +2 more 2023-07-18
11548888 KRas G12C inhibitors James Gail Christensen, Christopher Ronald Smith, John P. Fischer, Aaron Craig Burns 2023-01-10
11492351 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-11-08
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-11-01
11479551 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-10-25
11453683 KRas G12D inhibitors Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more 2022-09-27
11267812 KRAS G12C inhibitors John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia +10 more 2022-03-08
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-01-11
11091495 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2021-08-17
10689377 KRas G12C inhibitors James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Adam Cook +7 more 2020-06-23
10647715 KRas G12C inhibitors Thomas P. Bobinski, Aaron Craig Burns, John Gaudino, Julia Haas, John Michael Ketcham +5 more 2020-05-12
10633381 KRas G12C inhibitors James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more 2020-04-28
10266542 EZH2 inhibitors Matthew Lee, Robert A. Galemmo, Jr., Thomas P. Bobinski 2019-04-23
10233152 LSD1 inhibitors Arkadii Vaisburg, James Gail Christensen, Robert A. Galemmo, Jr. 2019-03-19
10125134 KRas G12C inhibitors James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more 2018-11-13
10059668 LSD1 inhibitors Arkadii Vaisburg 2018-08-28